Fisher & Paykel Healthcare Corporation Limited (FPH)

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.00
  • Currency: Australian Dollars
  • Shares Issued: 573.76m
Select chart: 1 month | 3 month | 6 month | 1 year
 

Current

1 month

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-26 2,257.78 605.76 n/a n/a n/a -100% n/a 0.0%
31-Mar-27 2,518.58 705.52 n/a n/a n/a n/a n/a 0.0%
31-Mar-28 2,806.72 833.18 n/a n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
31-Mar-26 $3.94 0.00
31-Mar-27 $4.39 0.00
31-Mar-28 $4.89 0.00

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
31-Mar-2026 2,258 n/a 2,246 2,246 n/a 2,253
31-Mar-2027 2,519 n/a 2,506 2,504 n/a 2,528
31-Mar-2028 2,807 n/a 2,795 2,790 n/a n/a
 
Earnings
31-Mar-2026 n/a n/a n/a n/a n/a n/a
31-Mar-2027 n/a n/a n/a n/a n/a n/a
31-Mar-2028 n/a n/a n/a n/a n/a n/a
 
Dividend
31-Mar-2026 n/a n/a n/a n/a n/a n/a
31-Mar-2027 n/a n/a n/a n/a n/a n/a
31-Mar-2028 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 0 1 0 1 0
Buy 2 0 2 0 1 1
Neutral 6 0 6 0 7 7
Sell 2 0 2 0 2 3
Strong Sell 0 0 0 0 1 1
No. of Brokers 11 0 11 0 12 12
 
Average Rec 5.45 n/a 5.45 n/a 4.79 4.17

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

FPH Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.00
Shares Issued 573.76m

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 6
Sell 2
Strong Sell 0
Total 11
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page